Fig. 7.
Vaccine selection (in number of district-years) and person-days of malaria infection versus vaccine cost, over 5-year time horizon, in the baseline efficacy scenario
Vaccine selection (in number of district-years) and person-days of malaria infection versus vaccine cost, over 5-year time horizon, in the baseline efficacy scenario